Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Bob wachter - You Need To See This

The era of Doctor AI is already here

Artificial intelligence is opening access to medical information in an entirely new way.

Are there places you should still mask in, forever? Three experts weigh in

Are there places you should still mask in, forever? Three experts weigh in

NPR asked COVID-19 experts how we should keep weighing risk as we enter the fourth year of the pandemic.

Vaccine advocate, on science, truth, and why he’s not a fan of the latest COVID boosters

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

The Philadelphia Inquirer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Pfizer’s Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long COVID, a study found.

Tribune News Service

Q&A: You’re feeling cruddy. Is it flu? COVID? Here’s why it matters

SAN JOSE, Calif. -- If you’re feeling really cruddy right now, join the crowd. Yes, you might have COVID. Yet again, this time it might be the flu — or just a really bad cold that is making the rounds.

Tribune News Service

Omicron boosters: Do I need one, and if so, when?

Updated COVID boosters are now available for anyone age 12 or older. The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait.

New dominant Omicron subvariant defies immunity from previous infections

BA.5 is so catchy — and different enough from previous versions — that even those who've already caught Omicron may not have to wait long before winding up with the virus again.

inkl

Read news from The Economist, FT, and more,
with one subscription

Stuck in the great COVID in-between

Stuck in the great COVID in-between

Life in a COVID world is getting awkward again as Americans rush headlong back to their old ways of life even as case counts rise and new variants threaten to dash their hopes.

Omicron (part two) may be coming

Omicron (part two) may be coming

“I think late April is when things will start to get really worrisome,” one epidemiologist said

1

People

William Schaffner

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Vanderbilt University Medical Center

University of California-San Francisco

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

infectious disease

Places

372,199 stories

138,613 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play